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The US Food and Drug Administration’s
Proposed Rule to Increase Regulation
of Indoor Tanning Devices
Tanning bed use, particularly among teen girls and
young adult women, has become a modern-day epi-
demic in the past 20 years. Numerous studies have
established the link between indoor tanning use and
skin cancer, including melanoma. Reducing the harms
of indoor tanning is one of 5 goals outlined in the 2014
US Surgeon General’s “Call to Action to Prevent Skin
Cancer.”1 Consistent with the Call to Action, on Decem-
ber 22, 2015, the US Food and Drug Administration
(FDA) issued a proposed rule with the following restric-
tions for sunlamp products (ie, indoor tanning beds and
booths): (1) to ban their use among individuals younger
than 18 years; (2) to require prospective users to sign a
risk acknowledgment certification; and (3) to provide
user manuals to customers and tanning facility opera-
tors on request.2
Theproposed rule toban indoor tanningamongmi-
nors younger than 18 years represents a landmark step
in the regulation of sunlamp products in the United
States. To date, restricting indoor tanning by age has
been done on a state-by-state level. Successful state-
wide legislative efforts, leading to prohibition of indoor
tanning forminorsyounger than 18years in 13states,un-
doubtedly led theFDAtoproposeanational banamong
minors. Spurred by extensive public health advocacy
coupledwithdataon theharmsandgrowinguseof tan-
ningbeds, youthaccess restrictionshavespreadquickly
across the country in the past 4 years (the first ban for
use by those < 18 years went into effect in California in
January2012). It isnoteworthy,andappropriate, that the
proposed rulemakes no provision for parental consent
of indoor tanningamongminors,which is included incur-
rent regulations for 17 states, but commonly flouted by
indoor tanning salons.3 Parental consentprovisions are
also inconsistent with regulations for other health-
damaging products, such as laws that prohibit the sale
of tobacco products to minors.
Prohibiting indoor tanning among individuals
younger than 18 years is an important step in reducing
teen use, which now exceeds 30%among non-Hispanic
white girls ages 16 and 17 years (32%and 39%ofwhom,
respectively, report indoor tanning at least once in the
past year).4 Future research evaluating the impact of
the ban on use by those younger than 18 years is
needed, including ongoing surveillance of indoor tan-
ning rates and practices among minors and adults, as
well as epidemiologic and economic analyses of skin
cancer morbidity and mortality. Research on the impact
of the ban on age of indoor tanning initiation may be
especially important given that a ban on use by those
younger than 18 years does not entirely remove tanning
from the high school years, a time when many individu-
als adopt the behavior. Given that most tanners initiate
indoor tanning before the age of 21 years, ban on use by
those younger than 21 years could have a more signifi-
cant impact on indoor tanning-related skin cancer mor-
bidity and mortality. To thwart the harms of indoor tan-
ning, Brazil and Australia have prohibited indoor tanning
for all individuals. Research is needed to establish the
impact of different indoor tanning bans (eg, for those
< 18 years, < 21 years, all individuals) on skin cancer out-
comes and health care costs.
The proposed rule requires prospective adult users
to sign a 1-page risk acknowledgment certification form
highlighting indoor tanning risks, contraindications, and
precautionary measures prior to indoor tanning and
every 6 months thereafter. We suggest that text be
added to the certification to counter the false claims
commonly touted by the industry regarding health
benefits associated with indoor tanning (eg, reduced
risk of certain cancers, optimal production of vitamin
D). The certification includes language suggesting that
people with a personal or family history of skin cancer
should consult their physician. We suggest that this
language be modified to more definitively state that
such individuals should avoid using indoor tanning
devices. Future research should also examine the opti-
mal content and format of the certification and its
impact on a range of outcomes among prospective
and current indoor tanners, including emotional reac-
tions, perceived risks of indoor tanning, attitudes,
beliefs, intentions, and behaviors. Drawing on sub-
stantial evidence related to tobacco warnings, and
nascent research on indoor tanning warnings, this
research should focus on message framing and the use
of text and graphic imagery.
The proposed restrictions are subject to 2 broad
considerations. First, they pertain only to operators of
indoor tanning facilities, defined as individuals who of-
fer for sale the use of sunlamp products. Thus, it is un-
clear if they would apply to apartment buildings, fit-
ness facilities, or other locations where indoor tanning
is available at no direct expense to the user. A recent
study revealed that41%of indoor tanners reportedhav-
ing ever tanned in locations other than traditional in-
door tanningsalons.5Tanning facilityoperatorsmayalso
considerways tocircumventanynewregulations, forex-
amplebyproviding access to sunlampproducts for free
to minors who purchase other services (eg, spray
tanning). We encourage the US Food and Drug Admin-
istration (FDA) and state agencies to apply the pro-
posed rule across diverse commercial and residential
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(eg,apartmentbuildings)settingswheresunlampproductsareused.
A further consideration of the proposed regulations is the poten-
tial unintended consequence of increasing tanning bed use in pri-
vate homes, which would be unsupervised and unregulated. Re-
search is needed to examine the impact of theproposed legislation
on the locations where people use tanning beds.
Second, the impact of any resulting legislation will depend, in
large part, on how well compliance with enforcement provisions is
monitored and actually enforced. An analysis of the first 6 states to
enact tanning bans for minors revealed considerable variability in
their enforcement provisions.6 For example, all of the statutes
stipulated penalties for violations, but only 3 states established tan-
ning facility inspections and specified the department or agency
responsible for enforcement. If the proposed rule is enacted, the
FDA and relevant state and local agenciesmust coordinate enforce-
ment provisions, compliance monitoring of tanning facility opera-
tors, and enforcement of violations. Comprehensive monitoring of
compliance will likely require states to invest necessary resources
to hire, train, and supervise tanning facility inspectors. Ongoing
efforts will also be required to evaluate enforcement activities and
outcomes.
In conclusion, we consider the proposed rule to be a timely and
importantnextstep inaddressingthesignificantharmsof indoor tan-
ning in theUnitedStates.Asoutlinedherein, however, several issues
warrant attention tomaximize the public health benefits of the rule,
and research is needed to examine the impact of bans and to deter-
mine the optimal age group to target. Going forward, public health
advocatesandthoseworkingtoprotectyouthandyoungadults from
thedamagingeffectsof tanningbedusecandraw invaluable lessons
from tobacco control campaigns. Legislative efforts and landmark
regulations related to indoor tanningare important componentsof a
larger comprehensive public health strategy that should also em-
braceprice regulation, taxation, advertising restrictions, and theuse
ofmassmedia. Inaddition, thesameactiveandthrivingcoalitionsthat
have spearheaded the most recent initiatives to restrict indoor tan-
ning should expandandwork in a sustained fashion towarddramati-
cally reducing theestimated419000casesof skin cancer causedby
indoor tanning each year in the United States.7
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